Skip to content
Sign in
Public funderBacked 2 network startups

U.S. National Science Foundation (NSF)

US federal agency funding startups through non-dilutive SBIR/STTR grants (America's Seed Fund); backed G-Space and BioSapien.

Alexandria, United States
Ticket
—Not published
Assets under management
—
Founded
—
Stages
Pre-seedto Seed
Network startups backed
2
Co-investors
0

How they invest

High-risk, high-impact technology innovation from US small businesses, through SBIR/STTR Phase I and II grants. Science depth and commercial potential are both scored.

Stage and ticket

Pre-seed and Seed; non-dilutive (observed Phase I ~$245K-$256K).

Geography

United States (US small business eligibility).

What makes them say yes

  • Technical innovation with unproven feasibility
  • Credible commercialisation plan
  • US small-business eligibility

Red flags

  • Incremental technology
  • Ineligible (non-US) companies

Sectors

Not published

Stages

  • Pre-seed
  • Seed

Geographies

  • United States

How to approach

G-Space and BioSapien (NSF grantees) can share their experience. Submit a Project Pitch first, as required by NSF SBIR.

Portfolio

2 network startups · no other company

Space software and oncology drug delivery: deep-tech grantees across fields.

Gaps in the portfolio

  • Biotech tools
  • Advanced materials
  • Assistive technology

Network startups

  • BioSapienSWC 2026 Top 10

    United Arab Emirates · Biotech & life sciences

    3D-printed biodegradable MediChip implant delivering chemotherapy locally at the tumour site, now in colorectal cancer trials in the UAE.

  • G-Space, IncSWC 2026 Finalist

    United States · Space

    Former NASA scientist's physics-informed AI platform telling biotech and materials firms where microgravity R&D and manufacturing actually pay off.

    • NSF SBIR Phase I grantSource$245K

Network startups that fit

5 analysed

Tufts spin-off with an IRB-approved ingestible capsule that samples small-intestine microbiome and contents non-invasively.

Tufts ingestible gut-sampling capsule validated in animals with IRB approval: high-risk biomedical innovation ideal for SBIR Phase I/II.

55%confidence

Evidence from the records

  • “Ingestible small intestine sampling capsule”
  • “Capsule validated in 3 large animal models”
Intro path
G-Space founder (NSF grantee).
First step
Submit an NSF SBIR Project Pitch.

Davis biotech using baker’s yeast to deliver RNAi that kills insect pests, starting with cockroaches, without hazardous chemicals.

Yeast-delivered RNAi biopesticides from Davis, founded 2025: novel biotech with feasibility to prove.

50%confidence

Evidence from the records

  • “Yeast-based RNAi biopesticides”
  • “Pre-commercial biotech startup founded in 2025”
First step
Submit an NSF SBIR Project Pitch.

US manufacturer casting custom shock- and vibration-protection parts on demand from a patented PFAS-free foam, with samples in two days.

Patented PFAS-free foam with early customers: advanced-materials innovation with commercial pull.

40%confidence

Evidence from the records

  • “PFAS-free protective foams”
  • “patented PFAS-free foam”
First step
Submit a Project Pitch on PFAS-free materials.

US deep-tech start-up selling Caldera Engine, a cloud platform coupling physics simulation of suspensions with AI to discover materials faster.

Physics modeling plus AI for materials discovery, Techstars alumnus: computational innovation suited to SBIR.

40%confidence

Evidence from the records

  • “Physics modeling + AI for materials discovery”
  • “Pre-seed”
Intro path
Techstars (Monte Caldera investor).
First step
Submit a Project Pitch.

On-device vision smart glasses that convert obstacles into directional haptic cues for blind and visually impaired people.

Haptic navigation glasses for blind users with 8 daily testers: assistive technology with social impact.

35%confidence

Evidence from the records

  • “Assistive technology for the visually impaired (haptic smart glasses)”
  • “According to the founder, 8 blind people wear the glasses daily”
First step
Submit a Project Pitch.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

No co-investment documented yet.

Sources